US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Madrigal Pharmaceuticals, Inc. | $502.47 | -3.1% | $11.41B | -39.1 | 48.1% | — | Healthcare | 64% | 864.2% | ||
| 2 | Metsera, Inc. | $70.50 | 0% | $7.43B | -34.7 | — | — | Healthcare | 194% | — | ||
| 3 | Rhythm Pharmaceuticals, Inc. | $92.31 | 7.9% | $6.3B | -29.7 | -13% | 0.1% | Healthcare | 43.3% | 58.7% | ||
| 4 | Terns Pharmaceuticals, Inc. | $52.97 | 0.1% | $4.64B | -47.3 | 12.7% | — | Healthcare | 1505.1% | — | ||
| 5 | Akero Therapeutics, Inc. | $54.65 | 0% | $4.5B | -14.6 | 0.3% | — | Healthcare | 21.7% | — | ||
| 6 | Viking Therapeutics, Inc. | $31.31 | -1.4% | $3.63B | -9.8 | -260% | — | Healthcare | 6.2% | — | ||
| 7 | NewAmsterdam Pharma Company N.V. | $29.89 | 0.1% | $3.42B | -17.4 | 33.5% | — | Healthcare | 47.7% | -50.6% | ||
| 8 | Structure Therapeutics Inc. | $41.10 | -4.5% | $2.37B | -17.1 | -2.6% | — | Healthcare | 49.2% | — | ||
| 9 | MBX Biosciences, Inc. Common Stock | $29.60 | 0.5% | $1.32B | -16.0 | -43.1% | — | Healthcare | 145.2% | — | ||
| 10 | Maze Therapeutics, Inc. | $26.56 | -1.4% | $1.28B | 341.4 | — | — | Healthcare | 154.9% | — | ||
| 11 | Septerna, Inc. | $24.13 | -2.8% | $1.08B | -21.9 | — | — | Healthcare | 237% | — | ||
| 12 | MannKind Corporation | $2.86 | 1.8% | $880M | 143.0 | -78.4% | — | Healthcare | -42.3% | 22.2% | ||
| 13 | Lexicon Pharmaceuticals, Inc. | $1.65 | 3.1% | $699M | -11.8 | 78.3% | — | Healthcare | 129.2% | 60.2% | ||
| 14 | BioAge Labs, Inc. | $16.68 | 0.4% | $600M | -7.4 | 81.7% | — | Healthcare | 301.9% | — | ||
| 15 | Genfit S.A. | $8.95 | 4.1% | $448M | 256.9 | -212.8% | — | Healthcare | 97.6% | 9.8% | ||
| 16 | Niagen Bioscience Inc | $4.82 | -2.2% | $385M | 24.1 | 1187.3% | — | Healthcare | -43% | 36% | ||
| 17 | Altimmune, Inc. | $3.06 | 1.3% | $339M | -3.1 | 24.6% | — | Healthcare | -43.6% | 105% | ||
| 18 | DiaMedica Therapeutics Inc. | $6.25 | 3.3% | $325M | -10.4 | -26.8% | — | Healthcare | 56.3% | — | ||
| 19 | Rezolute, Inc. | $3.29 | -0.3% | $314M | -3.4 | 24.4% | — | Healthcare | -20.1% | — | ||
| 20 | Inventiva S.A. | $5.42 | 2.8% | $282M | -1.3 | -91.2% | — | Healthcare | 53.5% | 15.4% | ||
| 21 | vTv Therapeutics Inc. | $31.80 | -2.2% | $268M | -9.9 | 4% | — | Healthcare | 46.4% | -102.4% | ||
| 22 | Sagimet Biosciences Inc. | $7.72 | -2.3% | $250M | -4.9 | -10.5% | — | Healthcare | 115% | — | ||
| 23 | Galectin Therapeutics Inc. | $2.23 | -2.6% | $144M | -2.9 | 19.2% | 0.1% | Healthcare | 70.2% | — | ||
| 24 | Aardvark Therapeutics, Inc. Common Stock | $5.47 | 3.8% | $119M | -1.9 | 1.1% | — | Healthcare | -48.1% | — | ||
| 25 | Fractyl Health, Inc. Common Stock | $0.69 | -4.6% | $106M | -0.4 | -21.2% | — | Healthcare | -57.4% | -100% | ||
| 26 | Entera Bio Ltd. | $1.16 | 4.5% | $45M | -4.6 | 110.3% | — | Healthcare | -49.3% | 25.3% | ||
| 27 | Lipocine Inc. | $2.33 | 1.7% | $13M | -1.4 | — | — | Healthcare | -31.9% | -82.3% | ||
| 28 | MetaVia Inc. | $1.42 | -3.4% | $7M | -0.0 | 71.5% | — | Healthcare | 84.4% | — | ||
| 29 | Galmed Pharmaceuticals Ltd. | $0.59 | 0.3% | $982282 | -0.1 | -2412% | — | Healthcare | -55.3% | — | ||
| 30 | XORTX Therapeutics Inc. | $2.77 | -7% | $771415 | -0.2 | 52% | — | Healthcare | -46.9% | — | ||
| 31 | Hepion Pharmaceuticals, Inc. | $0.05 | -1.7% | $617039 | -0.1 | 99.2% | — | Healthcare | -82.2% | — |
Showing 31 stocks